<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CEWU8O8Y</identifier><date>2023</date><creator>Pečnik, Matija</creator><relation>documents/doc/C/URN_NBN_SI_doc-CEWU8O8Y_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CEWU8O8Y_001.txt</relation><format format_type="issue">2</format><format format_type="type">article</format><format format_type="extent">str. 34-38</format><identifier identifier_type="COBISSID_HOST">166099459</identifier><identifier identifier_type="ISSN">2820-5006</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CEWU8O8Y</identifier><language>slv</language><publisher publisher_location="Ljubljana">Fakulteta za farmacijo, ŠSSFD</publisher><source>Placebo</source><rights>InC</rights><subject language_type_id="slv">klinična preizkušanja</subject><subject language_type_id="slv">molekulsko sidranje</subject><subject language_type_id="slv">prenamemba zdravilnih učinkovin</subject><subject language_type_id="slv">Rak (medicina)</subject><subject language_type_id="slv">rakava obolenja</subject><subject language_type_id="slv">rešetanje visoke zmogljivosti</subject><subject language_type_id="slv">terapija raka</subject><subject language_type_id="slv">Zdravilne učinkovine</subject><subject language_type_id="slv">Zdravljenje</subject><title>Prenamemba zdravilnih učinkovin (»drug repurposing«) za terapijo raka</title></Record>